Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPulmonologyuniverahealthcare NIPPV Coverage & Prior Auth | Op…
    Ask Trek AI about this page

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    ModifieduniverahealthcarePolicy 1.01.57

    Home Non-Invasive Positive Pressure Ventilation (NIPPV) Devices for Respiratory Insufficiency and Failure

    Customize your policy alerts

    Sign up for univerahealthcare Policy 1.01.57 alerts

    Get alerted when Policy 1.01.57 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Medical necessity and coverage criteria for home non-invasive positive pressure ventilation devices (BPAP and non-invasive home mechanical ventilation) for individuals with respiratory insufficiency due to neuromuscular or thoracic restrictive disease.

    Policy Summary
    Payeruniverahealthcare
    PolicyHome Non-Invasive Positive Pressure Ventilation (NIPPV) Devices for Respiratory Insufficiency and Failure
    Policy CodePolicy 1.01.57
    Change TypeNew policy introducing home ventilation device criteria
    Effective DateOct 15, 2026
    Last ReviewJun 18, 2026
    Next Review DateJun 1, 2027
    Key ActionObtain prior authorization with clinical documentation demonstrating device-specific medical necessity criteria for BPAP or home ventilator devices.
    SourceLink
    POLICY UPDATE CHANGES

    New policy to address home ventilation devices for respiratory failure.

    E0470/E0471/E0466Device codes referenced
    FVC <80%/ <50%Spirometry threshold
    PaCO2 ≥45ABG hypercapnia
    70% / ≥4hCompliance threshold
    1-monthRental allowed
    06/18/26Committee approval

    Coverage Criteria for Home Non-Invasive Positive Pressure Ventilation

    BPAP (E0470/E0471) — Neuromuscular or Thoracic Restrictive Disease

    Covered when ANY of the following are met for individuals with neuromuscular or thoracic restrictive disease:

    BPAP criteria: 1) Documented decrease in forced vital capacity (FVC) to <80% predicted with symptoms (eg, dyspnea, orthopnea, fragmented sleep) OR FVC <50% predicted without symptoms; 2) Maximal inspiratory pressure (MIP) <60 cm H2O; 3) Oxygen desaturations ≤88% for ≥5 cumulative minutes during sleep oximetry (minimum recording time 2 hours) while breathing room air or prescribed FiO2; 4) Arterial blood gas (ABG) showing PaCO2 ≥45 mm Hg while awake and breathing room air or prescribed FiO2.see individual nodes

    Exact measurement conditions specified in each node

    Non-invasive Home Mechanical Ventilation (E0466)

    Considered medically appropriate when ALL of the following are met:

    Home mechanical ventilation requirements:
    Policy Summary
    Payeruniverahealthcare
    PolicyHome Non-Invasive Positive Pressure Ventilation (NIPPV) Devices for Respiratory Insufficiency and Failure
    Policy CodePolicy 1.01.57
    Change TypeNew policy introducing home ventilation device criteria
    Effective DateOct 15, 2026
    Last ReviewJun 18, 2026
    Next Review DateJun 1, 2027
    Key ActionObtain prior authorization with clinical documentation demonstrating device-specific medical necessity criteria for BPAP or home ventilator devices.
    SourceLink
    On This Page
    Coverage Criteria for Home Non-Invasive Positive Pressure VentilationCoding and Clinical ThresholdsAuthorization, Documentation, and Billing Actions for ProvidersBackground and ScopeDefinitions and Device DescriptionsPolicy Revision History
    1) Meets criteria for a BPAP device (see BPAP criteria); AND 2) One of the following indications is present: advanced BPAP with iVAPS (E0471) does not meet needs due to requirement for auto-EPAP; concomitant obstructive sleep apnea; bulbar dysfunction; concomitant COPD; daytime dyspnea at rest; non-invasive ventilation needed >10 hours/day; extreme loss of function with vital capacity <30%; worsening daytime hypercapnia with need for mouthpiece ventilation; or daytime (battery-operated) ventilatory use required to reduce hypercapnia or dyspnea.
    see node details

    Many specific clinical scenarios listed as indications for escalation

    Dual or multifunction ventilator (E0468, E0467)

    Considered medically necessary when ALL of the following are met:

    Core criteria: Meets criteria for a home mechanical ventilator (E0466).
    Function need: There is documentation supporting the need for one or more additional functions on the device (eg, oxygen concentrator, cough stimulator, suction pump, nebulizer) and the member has not previously received any of these functions as separate devices.

    BPAP without backup rate (E0470) for hypoventilation syndrome

    Considered medically appropriate when ALL of the following are met:

    Diagnosis: Individual has a hypoventilation syndrome diagnosis.
    ABG threshold: An initial ABG showing PaCO2 ≥45 mm Hg performed while awake and breathing the patient's prescribed FiO2.PaCO2 ≥45 mm Hg

    Chunk 22

    Spirometry demonstrates FEV1/FVC ≥70%.FEV1/FVC ≥70%

    Chunk 23

    One of the following: Either: (1) An ABG taken when asleep or immediately on waking shows PaCO2 worsened by ≥10 mm Hg compared to the qualifying awake ABG; OR (2) PSG or HST demonstrates oxygen saturation ≤88% for ≥5 cumulative minutes (minimum 2-hour recording) not caused by obstructive upper-airway events.PaCO2 worsening ≥10 mm Hg OR SpO2 ≤88% ≥5 min

    Chunks 24-25

    BPAP with backup rate (E0471) for hypoventilation syndrome

    Considered medically appropriate when ALL of the following are met:

    Current use: Individual is currently using a BPAP device without backup rate.

    Chunk 26

    Spirometry demonstrates FEV1/FVC ≥70%.FEV1/FVC ≥70%

    Chunk 27

    PaCO2 worsening: An awake ABG on prescribed FiO2 shows PaCO2 has worsened by ≥10 mm Hg compared to the ABG used to qualify for E0470.PaCO2 worsening ≥10 mm Hg

    Chunk 28

    Non-invasive home mechanical ventilation devices (E0466) for hypoventilation syndrome

    Considered medically appropriate when ALL of the following are met:

    Base criteria: Meets BPAP criteria (see BPAP policy statement).

    Chunk 32

    Indications (one of): One of the following: advanced BPAP with iVAPS does not meet needs and requires auto-EPAP; non-invasive ventilation needed >10 hours/day; severe hypoxemia with FiO2 >40% or >5 L/min; OR BPAP was tried and failed (documentation of attempted daily use) with persistent hypercapnia defined as either awake PaCO2 ≥45 mm Hg or awake venous/etCO2/tcCO2 ≥50 mmHg.See component nodes

    Chunks 33-37

    NIPPV (E0466) for hypoventilation syndrome

    Covered when ALL of the following are met:

    Indication and trial

    • Hypercapnia criteria: One of: awake PaCO2 ≥45 mm Hg; OR awake venous PCO2, end-tidal PCO2, or transcutaneous PCO2 ≥50 mm Hg.PaCO2 thresholds as stated

      See chunks 36-37

    Dual or multifunction ventilators (E0468, E0467)

    Covered when BOTH of the following are met:

    Device-level need: Meets criteria for a home mechanical ventilator (E0466); AND documentation supports need for one or more additional functions (oxygen concentrator, cough stimulator, suction pump, nebulizer) and the member has not received these functions individually.

    See chunks 38-39

    BPAP without backup rate (E0470) for COPD-related CRF

    Covered when ALL of the following are met:

    COPD CRF BPAP (E0470): 1) Individual has chronic respiratory failure due to COPD; 2) Individual cannot tolerate high-intensity NIV or a backup rate is not needed; 3) Hypercapnia demonstrated by awake ABG PaCO2 ≥52 mm Hg while breathing prescribed FiO2; AND 4) Sleep apnea has been ruled out as the cause of hypercapnia.PaCO2 ≥52 mm Hg

    See chunks 40-42

    BPAP with backup rate (E0471) for COPD-related CRF

    Covered when ALL of the following are met:

    COPD CRF BPAP with backup (E0471): 1) Meets criteria for BPAP without backup rate (E0470); AND 2) Sleep oximetry showing oxygen saturation ≤88% for ≥5 cumulative minutes (minimum 2-hour recording) while receiving oxygen at 2 LPM or prescribed FiO2; AND 3) An awake ABG on prescribed FiO2 shows PaCO2 has worsened by ≥10 mm Hg compared to the ABG used to qualify for E0470.Saturation and PaCO2 change thresholds as stated

    See chunks 43-44 and 48

    E0466 for COPD-related CRF (advanced non-invasive ventilator)

    Covered when ALL of the following are met:

    Baseline BPAP criteria: Meets criteria for BPAP without backup rate (E0470).

    Refer to Policy Statement VIII / chunks 49

    Additional E0466 indications: One of: requires oxygen therapy at FiO2 ≥36% or ≥4 L nasal; OR requires ventilatory support >8 hours per 24-hour period; OR requires alarms/internal battery because patient cannot effectively breathe on their own for more than a few hours and an unrecognized interruption would likely be life-threatening; OR advanced BPAP with iVAPS (E0471) does not meet needs and the individual is unable to achieve one of: normalization of PaCO2 (<46 mm Hg), stabilization of a rising PaCO2, 20% reduction in PaCO2 from baseline, OR improvement in at least one symptom associated with chronic hypercapnia (eg, headache, fatigue, dyspnea, confusion, or sleep quality).See individual bullets for numeric thresholds

    See chunks 50-55

    Home mechanical ventilator (E0466) for chronic respiratory failure due to COPD

    Covered when ALL of the following are met

    Primary condition: Chronic respiratory failure (CRF) due to COPD.

    Advanced BPAP insufficiency criteria

    • PaCO2 or symptom response: Stabilization of a rising PaCO2 OR 20% reduction in PaCO2 from baseline OR improvement of at least one symptom associated with chronic hypercapnia.

      Must document failure of iVAPS to meet needs

    Dual or multifunction ventilators (E0468, E0467)

    Covered when BOTH of the following are met

    Home ventilator criteria: Meets criteria for a home mechanical ventilator (E0466); AND documentation supports need for one or more additional non-ventilator functions (oxygen concentrator, cough stimulator, suction pump, nebulizer) and the member has not previously received these functions as separate devices.

    Both conditions required

    BPAP (E0471/E0470) for obstructive or central sleep apnea

    Covered when ALL of the following are met for OSA, and for central/complex sleep apnea when ONE of the listed indications is met

    OSA indications: For OSA: Failed or cannot tolerate CPAP; demonstration of resolution/control of respiratory events and improved tolerance with BPAP after appropriate titration; and individual is stable on current treatment.
    Central/complex sleep apnea indications: One of: central hypopnea/apnea >50% of total AHI; OR central hypopnea/apnea index >5 events/hour; OR documentation supporting effectiveness of BPAP during PSG; OR symptomatic patients with excessive sleepiness, disrupted sleep, or significant desaturations despite optimized CPAP.

    Any one indication qualifies

    Hospital discharge with home ventilator or BPAP with backup

    Covered when BOTH of the following are met

    Recent ventilator requirement: Individual required a ventilator or BPAP device within 24 hours prior to discharge.
    Post-discharge risk: Individual is at risk of rapid symptom exacerbation or rise in PaCO2 after discharge.

    Continuation of use

    Compliance: Use of device for ≥70% of nights for ≥4 hours per night during a consecutive 30-day period.70% of nights; ≥4 hours/night; 30 consecutive days

    Required to consider continuation medically appropriate

    Continuation of NIPPV

    Covered when ALL of the following are met

    Continuation compliance: Patient uses device >=4 hours per night on >=70% of nights during a consecutive 30-day period.70% nights; >=4 hours/night; 30 consecutive days

    Applies to diagnoses of COPD, OSA, and hypoventilation syndrome

    Repair of NIPPV (non-warranty)

    Repair considered medically appropriate when ALL of the following physician documentation items are provided and BOTH device function criteria are met

    Required documentation: Physician documentation includes: date of DME initiation; manufacturer warranty information (if applicable); and attestation that the patient has been compliant with use of the DME and will continue to benefit from it.
    Device function: The DME is no longer functioning adequately AND inadequate function interferes with activities of daily living; AND repair is expected to restore full functionality as defined by the manufacturer.

    Repair expected to restore manufacturer-defined full functionality

    Replacement of NIPPV (non-warranty)

    Replacement considered medically appropriate when EITHER of the following is met

    Replacement reasons: (1) DME is no longer functioning and has been determined non-repairable OR cost of repair exceeds replacement cost; OR (2) A change in the patient's condition makes the present unit nonfunctional and improvement is expected with replacement.

    Covered when device matches indicated clinical scenarios

    Covered indications and device descriptions

    Covered device uses: Bilevel positive pressure devices are used as respiratory assist devices for individuals with chronic respiratory failure: nocturnal management of chronic respiratory failure; long-term management of neuromuscular disorders with respiratory involvement; respiratory insufficiency due to severe kyphoscoliosis; and improvement of nighttime desaturation and hypoventilation in chest-wall disease.

    Based on BPAP description

    Advanced BPAP typical indications: Advanced BPAP devices (adaptive volume/pressure support with backup rate) are typically designed for complex or central sleep apnea, Cheyne-Stokes respiration, obesity hypoventilation syndrome, and other irregular ventilation patterns.

    From advanced BPAP description

    Multifunction ventilator features: Non-invasive dual or multifunction home mechanical ventilators combine mechanical ventilation with at least two additional respiratory functions such as supplemental oxygen delivery, cough assistance, suction, nebulizer, and oximetry in a single portable unit.

    From multifunction ventilator description

    Professional guideline–based coverage criteria

    Coverage and clinical-use guidance reflected from cited professional societies (condensed):

    CSA recommendations: Guidance suggests CPAP, bilevel with backup, or adaptive servo-ventilation over no therapy for adults with central sleep apnea across multiple etiologies (conditional recommendations, low/very low certainty).

    AASM 2025 guidance

    NMD indications for NIV: For neuromuscular disease, recommend NIV for any fall in FVC to <80% predicted with symptoms, FVC <50% without symptoms, MIP < -60 cm H2O, MEP <40 cm H2O, or hypercapnia (awake PaCO2 >45 mm Hg) or relevant PSG findings.

    Chest Physicians 2023 guidance

    Chronic stable hypercapnic COPD: Suggest nocturnal NIV in addition to usual care for chronic stable hypercapnic COPD (FEV1/FVC <0.70; resting PaCO2 >45 mm Hg) and recommend screening for OSA prior to long-term NIV; advise not initiating long-term NIV during acute admission and reassessing 2–4 weeks after resolution.

    ATS 2020 guidance

    PAP first-line for OSA: CPAP is first-line therapy for OSA; switch to BPAP when CPAP intolerance or persistent obstructive events at high CPAP pressures occur (eg, ~15 cm H2O).

    AASM/AASM-related guidance

    No explicit exclusions are stated in this policy segment. The document affirms that medical necessity criteria and device-specific coverage rules govern authorization decisions, and that contract-dependent product benefits may further limit coverage (e.g., if a product does not cover a service, the medical policy criteria do not apply).

    Providers should note that although this excerpt does not list standalone exclusions, other sections of the policy specify ineligible circumstances (see Multifunction device requirements, repair/replacement exclusions, and convenience items) that affect coverage determinations.

    Requests for dual- or multifunction ventilators (HCPCS: E0467, E0468) must include documentation that clearly supports the medical need for one or more additional device functions (e.g., oxygen concentrator, cough stimulator, suction pump, nebulizer). The member must not already have received the same function(s) as separate devices; lacking this documentation risks denial.

    When multifunction capability is requested, include clinical justification for each additional function and evidence that those functions are required concurrently with ventilation rather than being available from other covered equipment.

    If sleep apnea is the underlying cause of hypercapnia and has not been ruled out, criteria for BPAP without backup (HCPCS: E0470) are not met. Documentation must establish that hypercapnia is not attributable to untreated sleep-disordered breathing before E0470 is approved.

    Multifunction devices are considered medically necessary only when documentation demonstrates the need for additional non-ventilator functions and confirms that the member has not previously been provided those functions as standalone devices. Absent this documentation, multifunction device requests may be denied.

    Repairs or replacements for equipment damaged by patient neglect, theft, or abuse are ineligible for coverage. Coverage is also ineligible when another available source (e.g., homeowners, rental, auto, liability insurance) can reasonably cover the loss or damage.

    When alternate coverage exists, providers should direct members to the alternate source; requests for plan payment in these circumstances are subject to denial.

    Replacement of a properly functioning NIPPV device for convenience, aesthetics, or to obtain advanced technology is considered not medically necessary and is excluded. Accessories or components deemed not medically necessary or investigational in peer-reviewed literature are likewise ineligible.

    Requests that do not document loss of function, non-repairability, or a clinical change that renders the current device inadequate will not meet the replacement criteria.

    Devices intended solely to clean or sanitize BPAP equipment (for example, SoClean or SoClean 2 Go) are considered convenience items and are not eligible for coverage under this policy.

    The policy’s HCPCS/CPT/ICD-10 code lists may not be exhaustive. Specific codes could be excluded or not covered under certain circumstances; check the full policy and the member’s product benefit for applicability.

    Providers must submit the relevant procedure and diagnosis codes when requesting coverage, and be aware that codes alone do not guarantee coverage if other medical-necessity criteria are unmet.

    If a member’s product does not cover a particular service, the medical policy criteria do not apply. Coverage determinations are therefore subject to contract-level benefit limitations; verify product-specific benefit coverage before requesting authorization.

    This document segment does not include explicit statements labeled “Not Medically Necessary.” Coverage stance and exclusions are instead captured through the specific device criteria, repair/replacement rules, and explicit ineligibility statements elsewhere in the policy.

    Authorization for a home mechanical ventilator (HCPCS: E0466) generally requires prior trial and failure of BPAP (HCPCS: E0470 or E0471) with documentation of attempted daily use when persistent hypercapnia is the indication. Requests for E0466 without evidence of an adequate BPAP trial and daily-use documentation may be considered unsupported.

    Where BPAP had not been tried or trial documentation is absent, include objective measures (e.g., ABG or PCO2 monitoring) and a narrative explaining why BPAP trial was not feasible to reduce risk of denial.

    If an advanced BPAP mode such as iVAPS (referenced with HCPCS: E0471) adequately meets the patient’s ventilatory needs, escalation to a home mechanical ventilator (HCPCS: E0466) is not indicated. E0466 is considered only when advanced BPAP/iVAPS cannot achieve required physiologic goals (e.g., normalization or stabilization of PaCO2, ≥20% PaCO2 reduction, or improvement in hypercapnia-related symptoms).

    Document attempts to optimize advanced BPAP/iVAPS settings and the physiologic or symptomatic endpoints that were not achieved to support an E0466 request.

    Requests for HCPCS E0466 may be deemed not medically necessary if there is no documentation that advanced BPAP with iVAPS (HCPCS: E0471) is insufficient or that the listed PaCO2/symptom criteria for escalation are unmet.

    Prior authorization submissions for E0466 should therefore include evidence of failed advanced BPAP/iVAPS and the specific physiologic or symptom-based endpoints used to justify escalation.

    Replacement of a properly functioning home NIPPV device, its components, or accessories is considered not medically necessary. Requests to replace equipment for reasons other than non-repairability, excessive repair cost, or clinically driven changes in patient needs should be denied.

    BPAP devices that include volume- or pressure-based backup-rate features have not demonstrated effectiveness for treating obstructive sleep apnea (OSA). For OSA management, CPAP remains first-line; BPAP (with or without backup) is used when CPAP is not tolerated or does not control events.

    Because backup-rate BPAP has not shown effectiveness for OSA, requests for such devices to treat uncomplicated OSA should include documentation showing CPAP failure or intolerance and clinical justification for BPAP.

    The policy uses code-designation labels such as (E/I)=Experimental/Investigational and (NMN)=Not medically necessary/appropriate where applicable; review the full policy coding table to see code-specific designations and applicability.

    Coding and Clinical Thresholds

    Covered HCPCS CodesHCPCSCovered
    E0471BPAP with backup rate
    E0470BPAP without backup rate
    E0466Non-invasive home mechanical ventilation
    Covered HCPCS Ventilator CodesHCPCSCovered
    E0468Dual non-invasive home mechanical ventilator
    E0467Multifunction non-invasive home mechanical ventilator
    E0466Non-invasive home mechanical ventilation device
    E0470BPAP without backup rate
    E0471BPAP with backup rate / advanced ventilator (iVAPS referenced)
    Covered HCPCS Codes (non-invasive ventilator)HCPCSCovered
    E0466Non-invasive home mechanical ventilation device
    Covered HCPCS Codes (dual/multifunction)HCPCSCovered
    E0468Dual non-invasive home mechanical ventilator
    E0467Multifunction non-invasive home mechanical ventilator (VOCSN, VOCSN VC, VOCSN VC Pro)
    Covered HCPCS Codes (BPAP variants)HCPCSCovered
    E0470BPAP without backup rate
    E0471BPAP with backup rate / advanced BPAP with iVAPS referenced
    Covered HCPCS Codes - Home mechanical ventilatorHCPCSCovered
    E0466Non-invasive home mechanical ventilator
    Covered HCPCS Codes - BPAP variantsHCPCSCovered
    E0471BPAP with backup rate or advanced BPAP with iVAPS
    E0470BPAP without backup rate
    Covered HCPCS Codes - Dual/Multifunction ventilatorsHCPCSCovered
    E0468Dual non-invasive home mechanical ventilator (VOCSN, VOCSN VC, VOCSN VC Pro)
    E0467Multifunction non-invasive home mechanical ventilator (ventilation, oxygen, cough, suction and nebulization)
    Inclusive monitoring featureHCPCS
    A9279Monitoring feature/device, stand-alone or integrated, any type, including all accessories, components, and electronics, not otherwise classified
    CPT CodesCPT
    CPT CodesListed in policy (detailed list not present in this excerpt)
    CPT CodesCPT
    No codes listed
    CODINGHCPCSCovered
    A7027-A7039Accessories/supplies, code range for positive pressure airway devices (code range).
    A7044-Accessories/supplies, code range for positive pressure airway devices (code range).
    A9279Monitoring feature/device, stand-alone or integrated, any type, includes all accessories, components and electronics, not otherwise classified.
    E0466Home ventilator, any type, used with noninvasive interface, (e.g., mask, chest shell).
    E0467Home ventilator, multi-function respiratory device, also performs functions of oxygen concentration, drug nebulization, aspiration, and cough stimulation.
    E0468Home ventilator, dual-function respiratory device, also performs additional function of cough stimulation.
    E0470Respiratory assist device, bi-level pressure capability, without back-up rate feature, used with noninvasive interface.
    E0471Respiratory assist device, bi-level pressure capability, with backup rate feature, used with noninvasive interface.
    E0472Respiratory assist device, bi-level pressure capability, with backup rate feature, used with invasive interface.
    E0561Humidifier, nonheated, used with positive airway pressure device.
    1–10 of 11
    1/2
    CODINGICD-10
    E66.2Morbid (severe) obesity with alveolar hypoventilation.
    G12.0-G12.9Spinal muscular atrophy and related syndromes (code range).
    G35Multiple sclerosis.
    G47.00Insomnia, unspecified.
    G47.10Hypersomnia, unspecified.
    G47.20Circadian rhythm sleep disorder, unspecified type.
    G47.35Congenital central alveolar hypoventilation syndrome.
    G47.8Other sleep disorders.
    G47.9Sleep disorder, unspecified.
    I50.9Heart failure, unspecified.
    1–10 of 20
    1/2
    Forced Vital Capacity (FVC)
    FVC thresholdDocumented decrease in forced vital capacity (FVC) to <80% predicted with symptoms, or <50% predicted without symptoms
    Measurement contextMeasured percent predicted FVC from spirometry as documented in policy
    Clinical examples of symptomsSymptoms include dyspnea, orthopnea, or fragmented sleep (policy examples)
    Maximal Inspiratory Pressure (MIP)
    MIP thresholdMaximal inspiratory pressure (MIP) <60 cm H2O
    ContextUsed as an initiation criterion for NIV in neuromuscular disease per policy and guideline summary
    SignificanceMIP below threshold indicates inspiratory muscle weakness supporting need for ventilatory support
    Nocturnal Oxygen Saturation
    Nocturnal oxygen desaturationOxygen saturations ≤88% for at least five cumulative minutes during sleep oximetry (minimum recording time 2 hours)
    Recording conditionsApplies while breathing room air or prescribed FiO2 as applicable; for COPD-related CRF while receiving oxygen at 2 LPM or prescribed FiO2, whichever is higher
    Use caseSupports BPAP initiation or escalation when desaturations are not due to obstructive events
    Arterial PaCO2
    Arterial PaCO2 thresholdArterial blood gas (ABG) showing PaCO2 ≥45 mm Hg while awake and breathing room air or prescribed FiO2
    Definition implicationPolicy defines hypercapnia as PaCO2 >45 mm Hg
    Measurement contextABG obtained while awake on the patient's prescribed FiO2 per policy
    Arterial/venous/end‑tidal/transcutaneous PCO2
    Awake venous/end‑tidal/transcutaneous PCO2Awake venous blood gas PCO2, end‑tidal PCO2, or transcutaneous PCO2 ≥50 mm Hg
    Initial awake ABGInitial awake ABG PaCO2 ≥45 mm Hg qualifies for BPAP/NIPPV pathways
    Use for escalationElevated venous/etCO2/tcCO2 used as alternative CO2 documentation when ABG not available
    PaCO2 / PCO2 thresholds
    PaCO2 / PCO2 thresholds summaryAwake PaCO2 ≥45 mm Hg OR venous/end‑tidal/transcutaneous PCO2 ≥50 mm Hg; for COPD-related CRF with BPAP without backup the ABG PaCO2 threshold is ≥52 mm Hg
    ContextThresholds used to determine eligibility and device selection (BPAP vs home ventilator)
    DocumentationObjective CO2 measurements required per policy (ABG or validated alternatives)
    Change in PaCO2 on ABG
    PaCO2 change thresholdWorsening PaCO2 on ABG ≥10 mm Hg compared to the qualifying ABG (while awake on prescribed FiO2)
    Use caseIndication for upgrading BPAP without backup to backup-rate BPAP (E0471) or for diagnosing worsening hypoventilation
    Measurement timingComparison uses ABG done while awake on prescribed FiO2 and an ABG taken when asleep/just woken or subsequent awake ABG as specified
    Sleep Oximetry Desaturation
    Sleep oximetry desaturation thresholdOxygen saturations ≤88% for at least five (5) cumulative minutes during sleep oximetry (minimum recording time 2 hours)
    Recording and oxygen conditionApplies while breathing room air or prescribed FiO2; for COPD-related CRF applies while receiving oxygen at 2 LPM or prescribed FiO2
    Role in continuation/selectionUsed as criterion for BPAP initiation/escalation and for backup-rate BPAP selection in COPD CRF
    Oxygen Requirement
    Oxygen requirement thresholdRequires oxygen therapy at FiO2 ≥36% or ≥4 L per nasal cannula
    ApplicationOne of the indications for escalation to a home mechanical ventilator (E0466) in COPD-related chronic respiratory failure
    DocumentationPolicy requires documentation of current oxygen therapy and FiO2/flow rate
    Central Apnea‑Hypopnea Criteria
    Central apnea‑hypopnea criteriaCentral hypopnea/apnea constitutes >50% of the total AHI OR central hypopnea/apnea index >5 events/hour
    Alternate qualificationDemonstration of BPAP effectiveness during PSG or symptomatic patients despite optimized CPAP can also qualify
    ContextUsed to determine BPAP indication for central, complex, or treatment‑emergent sleep apnea
    Compliance Threshold for Continuation
    Compliance threshold (continuation)Use device for ≥70% of nights for ≥4 hours/night during a consecutive 30‑day period
    Measurement periodConsecutive 30‑day period as specified in policy
    Applies toContinuation of NIPPV for COPD, OSA, and hypoventilation syndrome
    Compliance Measurement
    Compliance measurement (definition)Patient uses device ≥4 hours per night on ≥70% of nights over a consecutive 30‑day period
    PurposeRequired documentation to consider continuation medically appropriate
    Data sourceDevice usage reporting as documented in policy
    Hypercapnia
    Hypercapnia definitionPaCO2 greater than 45 mm Hg
    Clinical relevanceHypercapnia is a defining feature of hypoventilation syndromes per policy
    Measurement methodUsually defined by arterial blood gas (ABG) PaCO2
    Hypoxemia
    Hypoxemia definitionPaO2 less than 60 mm Hg
    ContextMay be present in hypoventilation syndromes, especially during sleep
    MeasurementArterial blood gas measurement of PaO2 as specified
    Neuromuscular Disease NIV Initiation Thresholds
    NMD NIV initiation FVCFVC <80% predicted with symptoms OR FVC <50% predicted without symptoms
    Additional NMD thresholdsMIP < -60 cm H2O; MEP <40 cm H2O; awake PaCO2 >45 mm Hg (policy and guideline concordance)
    Clinical contextCriteria reflect recommendations from neuromuscular disease guidance for NIV initiation
    ALS NIV Initiation — FVC Example
    ALS example thresholdConsider NIV initiation around an FVC of ~75% in ALS patients (example from policy discussion)
    Evidence sourceSystematic review and guideline discussion cited in policy (Wang et al., 2019) and guideline summaries
    UseIllustrative example rather than strict cutoff; clinical judgment required
    Acute Respiratory Failure — pH Threshold
    Acute respiratory failure pH thresholdpH < 7.35 for acute or acute‑on‑chronic respiratory acidosis due to COPD exacerbation (ERS/ATS recommendation)
    Guideline sourceERS/ATS Clinical Recommendation for NIV in Acute Respiratory Failure (Rochwerg 2017) cited in policy
    ApplicationIndicates use of bilevel NIV in acute respiratory failure scenarios per guideline
    None Specified
    PlaceholderNone specified in this block
    NoteThis block is a placeholder per layout instructions
    ReferenceSee HCPCS code listings in policy for device codes

    Authorization, Documentation, and Billing Actions for Providers

    Prior Authorization

    Prior authorization required for BPAP and home ventilator codes

    Prior authorization is required for BPAP (HCPCS E0470/E0471) and non-invasive home mechanical ventilation (HCPCS E0466). Submit clinical documentation demonstrating that the device-specific medical necessity criteria in the policy are met.

    • Applicable codes: E0470, E0471, E0466
    Prior Authorization

    PA required for home ventilator devices (E0466/E0467/E0468)

    Prior authorization is required for specified home ventilator HCPCS codes (including E0466, E0467, E0468) and must show that the medical necessity criteria for a home mechanical ventilator are met.

    • Ensure documentation shows the patient meets the home mechanical ventilator criteria before submission
    Prior Authorization

    PA for multifunction / dual ventilators (E0467, E0468)

    Prior authorization is required for multifunction or dual ventilators (HCPCS E0467, E0468) and must include documentation supporting the need for device-level additional functions not previously provided individually.

    • Document which additional functions (oxygen concentrator, cough stimulator, suction pump, nebulizer) are required and confirm they were not previously provided separately
    Prior Authorization

    PA required showing HCPCS device criteria are met (e.g., E0466)

    Prior authorization is required for HCPCS-coded devices and requests must demonstrate device-specific clinical criteria are met (for example, E0466 for COPD-related chronic respiratory failure where advanced BPAP/iVAPS is insufficient).

    • Provide device-specific physiologic data and documentation of prior device trials per the criteria
    Prior Authorization

    Prior authorization for repair or replacement of non-warranty NIPPV

    Prior authorization/approval is required to authorize repair or replacement of non-warranty NIPPV devices; replacement is allowed when the device is non-repairable, repair cost exceeds replacement cost, or a change in patient condition makes the current unit nonfunctional and replacement is expected to improve function.

    • Include physician documentation items (date of DME initiation, warranty info, attestation of compliance) and device-function evidence
    Billing Rule

    One-month rental allowed during out-of-warranty repair; monitoring inclusive

    A one-month rental is allowed when a home ventilation device is malfunctioning and out of warranty while being repaired; monitoring features (HCPCS A9279) are considered inclusive to the positive airway pressure device.

    • Rental coverage limited to one month during out-of-warranty repair
    • Do not bill monitoring feature separately when included (A9279 considered inclusive)
    Note

    FDA clearance and code-specific coverage note

    FDA clearance is required for BPAP and home ventilators; coverage may depend on code-specific rules and exclusions listed by the payer.

    • Confirm devices have FDA approval before marketing/use and verify code-specific coverage rules
    Prior Authorization

    Obtain authorization when product requires it (HCPCS presence implies PA)

    Authorization is expected when device HCPCS codes are used and the member's product requires prior approval — providers should obtain authorization when the member's product requires it.

    • Presence of device HCPCS codes implies prior authorization may be required by the product
    Step Therapy

    Step-up to E0466 when BPAP is insufficient and listed indications present

    E0466 (non-invasive home mechanical ventilation) is authorized when BPAP (E0470/E0471) is insufficient and one of the listed indications for escalation (e.g., need for auto-EPAP, concomitant OSA, bulbar dysfunction, concomitant COPD, >10 hours/day NIV need) is present.

    • Document that advanced BPAP/iVAPS does not meet respiratory needs and specify which escalation indication applies
    Step Therapy

    Require documented BPAP trial and failure before escalation

    A documented trial and failure of BPAP with evidence of attempted daily use is required before progressing to some advanced ventilator devices (such as E0466).

    • Include documentation of attempted daily BPAP use and persistent hypercapnia per thresholds
    Step Therapy

    Document BPAP (E0470/E0471) trials and attempted daily use before device upgrade

    Providers should demonstrate trials of BPAP (E0470 or E0471) and, where applicable, failed BPAP with documentation of attempted daily use when requesting authorization for other ventilator devices.

    • Show which BPAP code was used (E0470 or E0471) and include compliance/trial details
    Step Therapy

    Use BPAP when CPAP fails or is not tolerated for OSA

    For obstructive sleep apnea, BPAP (E0471/E0470) is appropriate when CPAP has failed or is not tolerated and documentation demonstrates improved control of respiratory events and tolerance with BPAP.

    • Provide evidence of CPAP failure/intolerance and BPAP effectiveness (at least 2 weeks post-acute episode when applicable)
    Step Therapy

    Consider repair before replacement unless infeasible or cost-prohibitive

    Repair should be considered prior to replacement unless repair is non-feasible or cost-prohibitive compared with replacement.

    • Document why repair is not feasible or is more costly than replacement when requesting replacement
    Note

    BPAP with expiratory relief as CPAP-intolerance alternative

    BPAP with expiratory relief may be used as an alternative for patients who cannot tolerate the high constant pressure associated with CPAP.

    • Document intolerance to CPAP high pressures and rationale for selecting BPAP with expiratory relief
    Step Therapy

    CPAP first-line for OSA; escalate to BPAP if CPAP fails or events persist

    CPAP is supported as first-line therapy for OSA; transition to BPAP is appropriate if CPAP intolerance or persistent obstructive events at high CPAP pressures occur per AASM guidance.

    • Reference AASM guidance and document CPAP failure/intolerance or persistent events at high pressures
    Documentation Required

    Submit required clinical test results (FVC, MIP, sleep oximetry, ABG PaCO2)

    Provide required clinical test results to support medical necessity: measured FVC percent predicted, maximal inspiratory pressure (MIP), sleep oximetry showing cumulative desaturations, and arterial blood gas (ABG) with PaCO2.

    • FVC: <80% predicted with symptoms or <50% without symptoms
    • MIP: <60 cm H2O
    • Sleep oximetry: ≤88% for ≥5 cumulative minutes (min 2-hour recording)
    • ABG PaCO2: ≥45 mm Hg (awake)
    Documentation Required

    Document device functions and BPAP trial/usage

    Documentation must support the need for device functionalities and show attempted daily use when BPAP was tried and failed; include device function evidence when requesting multifunction devices or upgrades.

    • For multifunction devices, document which functions are required and that they were not already provided separately
    • For E0466 escalation, include documentation of attempted daily BPAP use
    Documentation Required

    Include objective CO2 measurements and ABG change comparisons

    Include objective CO2 measurements in documentation: awake ABG PaCO2 and, when applicable, venous/end-tidal/transcutaneous PCO2, and ABG comparisons showing changes (e.g., worsening ≥10 mm Hg versus qualifying ABG).

    • Awake PaCO2 thresholds: ≥45 mm Hg (general) and ≥52 mm Hg for COPD CRF E0470
    • Report worsening PaCO2 ≥10 mm Hg compared to qualifying ABG when required
    Documentation Required

    Document necessity of non-ventilator functions for multifunction devices

    Documentation must support the need for non-ventilator functions on multifunction devices and indicate that the member has not previously received those functions as separate devices.

    • Specify which non-ventilator functions are needed (oxygen, cough assist, suction, nebulizer)
    • Confirm member has not already received those functions separately
    Documentation Required

    Document ventilator/BPAP requirement within 24 hours before discharge

    For hospital discharge with a home ventilator or BPAP with backup, documentation must show the patient required a ventilator or BPAP within 24 hours prior to discharge and is at risk of rapid symptom exacerbation or rise in PaCO2 after discharge.

    • Include timing of ventilator/BPAP use within 24 hours of discharge and risk rationale
    Documentation Required

    Physician documentation required for repair/replacement requests

    For repair or replacement requests, include physician documentation items: date of DME initiation, manufacturer warranty information (if applicable), and an attestation that the patient has been compliant and will continue to benefit from the DME.

    • Provide DME initiation date and warranty details
    • Include clinician attestation of patient compliance and ongoing benefit
    Documentation Required

    Document inadequate device function and impact on ADLs for repair/replacement

    Document that the device is no longer functioning adequately, that inadequate function interferes with activities of daily living, and that repair is expected to restore full functionality per manufacturer definition.

    • Describe how inadequate function affects ADLs and why repair would restore functionality
    Documentation Required

    Require clinical reevaluation and corrective plan after failed initial trial

    Clinical reevaluation by the treating physician is required to document the etiology of failure to respond (e.g., persistent symptoms, improper fit) and a corrective plan (re-education, mask refitting) to re-qualify after an unsuccessful initial trial.

    • Include findings on etiology and planned corrective actions when submitting for re-qualification
    Documentation Required

    Document PAP education, mask fitting, and titration per AASM

    Provide documentation of PAP education, hands-on demonstration, careful mask fitting, acclimatization, and titration details when applicable, consistent with AASM pre-titration and titration guidance.

    • Document pre-titration education, mask fitting, and any repeat titration details
    Billing Rule

    Submit relevant CPT/HCPCS and ICD-10 codes with requests

    Submit all relevant CPT/HCPCS and ICD-10 codes listed in the policy when requesting coverage for home NIPPV devices to support claims and authorization requests.

    • Include HCPCS device codes (E0466, E0467, E0468, E0470, E0471), accessory codes, and applicable ICD-10 diagnosis codes
    Denial Risk

    Denial risk for missing required clinical documentation

    Lack of required clinical documentation (e.g., no FVC or MIP measurements, absent ABG demonstrating PaCO2 ≥45 mm Hg, or missing nocturnal oximetry findings) may lead to denial of the request.

    • Ensure FVC, MIP, ABG PaCO2, and sleep oximetry data are included when applicable
    Denial Risk

    Denial risk for insufficient documentation of home ventilator necessity

    Requests may be denied if documentation does not show the patient meets device-specific criteria for a home mechanical ventilator (E0466).

    • Provide evidence that the patient meets the listed indications for E0466
    Denial Risk

    Denial risk for missing required CO2 documentation

    Requests lacking documented hypercapnia by the policy thresholds (awake PaCO2 ≥45 mm Hg; or venous/end-tidal/transcutaneous PCO2 ≥50 mm Hg; or PaCO2 ≥52 mm Hg for COPD CRF BPAP without backup) may be denied.

    • Include specific CO2 measurements and indicate which threshold applies to the indication
    Denial Risk

    Denial risk for E0466 requests without evidence advanced BPAP/iVAPS failed

    A request for a home mechanical ventilator (E0466) for COPD-related chronic respiratory failure may be denied if documentation does not show that advanced BPAP with iVAPS (E0471) is insufficient or that one of the listed PaCO2/symptom criteria is met.

    • Document failure of advanced BPAP/iVAPS and inability to achieve PaCO2 goals or symptom improvement as specified
    Denial Risk

    Denial risk for dual/multifunction devices lacking function necessity evidence

    Dual (E0468) or multifunction (E0467) device requests may be denied if documentation does not support the need for one or more additional functions or if those functions were already provided individually.

    • Clearly state which additional functions are required and verify they were not previously provided separately
    Denial Risk

    Ineligible: damage/theft/alternate coverage — risk of denial

    Repairs or replacements for equipment damaged due to patient neglect, theft, or abuse, or when another coverage source is available, are ineligible for coverage and may be denied.

    • Do not submit repair/replacement claims for neglect/theft/abuse or when alternate coverage exists
    Denial Risk

    Loss of coverage risk if continuation trial criteria not met (90-day trial)

    Failure to meet continuation criteria during the initial 90-day trial may result in loss of coverage until a clinical reevaluation determines the etiology of failure and appropriate corrective actions are documented.

    • If continuation criteria not met, submit clinical reevaluation documenting etiology and corrective plan (re-education, mask refit)
    Billing Rule

    Coding and coverage limitations — verify with payer

    Codes listed in the policy may not be covered under all circumstances and the code list may not be all inclusive; verify coverage and code applicability with the payer.

    • Confirm code coverage and any payer-specific exclusions before submission
    Note

    Coverage depends on member product — verify contract benefits

    Services are contract dependent; if a product does not cover a service, the medical policy criteria do not apply — risk of denial if the member's product excludes the service.

    • Check the member's product benefits for coverage before submitting authorization requests

    Background and Scope

    Background: This policy addresses use of bilevel positive airway pressure (BPAP) devices (HCPCS E0470, E0471) and non-invasive home mechanical ventilation (HCPCS E0466, E0467, E0468) for respiratory insufficiency and failure related to neuromuscular or thoracic restrictive disease and other causes of chronic respiratory failure. It defines physiologic thresholds, escalation pathways (including when BPAP is insufficient and a home ventilator is indicated), and device-specific documentation and authorization expectations.

    Definitions and Device Descriptions

    BPAP — Device and Codes
    BPAP HCPCS codesE0470 (BPAP without backup rate); E0471 (BPAP with backup rate)
    DescriptionRespiratory assist devices with bi‑level pressure capability used with noninvasive interface
    Policy useUsed for chronic respiratory failure, neuromuscular disease, and selected sleep apnea indications
    Non‑invasive Home Mechanical Ventilation (E0466)
    E0466 descriptionHome ventilator, any type, used with noninvasive interface (HCPCS: E0466)
    IndicationConsidered when BPAP does not meet respiratory needs and additional indications (e.g., >10 hours/day ventilation, severe hypoxemia, inability to stabilize PaCO2) are present
    Policy noteStep‑up from BPAP to E0466 requires documented trial and failure of BPAP where specified
    Multifunction / Dual Ventilator
    Multifunction/dual ventilator descriptionDevices combining mechanical ventilation with at least two additional respiratory functions (e.g., supplemental oxygen, cough assist, suction, nebulizer) such as VOCSN devices
    HCPCS codesE0467 (multifunction), E0468 (dual‑function)
    Coverage requirementDocumentation must support need for one or more additional functions and the member must not have received those functions individually
    BPAP with Backup Rate (E0471)
    E0471 descriptionBPAP with backup rate (HCPCS: E0471) — BPAP device that includes a backup respiratory rate feature
    Indication for backupIndicated when a patient using BPAP without backup demonstrates PaCO2 worsening ≥10 mm Hg compared to qualifying ABG or other specified criteria
    Policy contextUsed for hypoventilation syndromes and COPD‑related CRF when backup rate criteria are met
    Multifunction/Dual Ventilator — VOCSN Example
    Multifunction ventilator featuresExample devices (VOCSN series) combine ventilation with oxygen concentrator, cough stimulator, suction pump, nebulizer and oximetry in one unit
    Clinical requirementDevice‑level need for additional functions must be documented; functions should not already be provided separately
    HCPCS linkageThese multifunction devices are reported with HCPCS E0467/E0468 per policy
    iVAPS — Advanced BPAP Mode
    iVAPS referenceiVAPS (Intelligent Volume Assured Pressure Support) is an advanced BPAP mode referenced in policy in the context of E0471 capabilities
    ImplicationIf iVAPS/advanced BPAP cannot achieve PaCO2 normalization, stabilization, or symptom improvement, escalation to E0466 may be considered
    Policy noteiVAPS mentioned as part of advanced BPAP functionality when considering need for home ventilator
    Central Sleep Apnea — Indications
    Central sleep apnea definition/indicationCentral hypopnea/apnea >50% of AHI OR central hypopnea/apnea index >5 events/hour (policy criteria)
    Alternate qualifiersDocumentation of BPAP effectiveness during PSG or symptomatic patients despite optimized CPAP may also indicate need
    Device applicabilityBPAP with or without backup (E0471/E0470) may be indicated for central/complex sleep apnea per policy
    Compliance (for Continuation) — Definition
    Compliance for continuation (definition)Use of the device for at least 70% of nights for four or more hours per 24‑hour period during a consecutive 30‑day period
    MeasurementDevice usage data over a consecutive 30‑day period required for continuation determinations
    Applies toContinuation decisions for COPD, OSA, and hypoventilation syndrome
    Fully Functional (Repair Outcome)
    Fully functional (repair outcome)Repair is expected to make the equipment fully functional as defined by the manufacturer
    ContextCriterion for approving repair of non‑warranty NIPPV devices
    Documentation requirementProvider must attest device is nonfunctional and repair will restore manufacturer‑defined functionality
    BPAP — Device Description
    BPAP definitionAirway support system delivering higher inspiratory and lower expiratory pressures via a mask; used for chronic respiratory failure and as alternative to CPAP
    Device typesIncludes simple BPAP (without backup) and advanced BPAP with adaptive modes and backup rate capabilities
    Clinical usesUsed at night for CRF, long‑term management of neuromuscular disorders, kyphoscoliosis, and chest‑wall disease desaturation/hypoventilation
    Advanced BPAP
    Advanced BPAP definitionBPAP with additional ventilation modes that automatically respond to real‑time respiratory needs (adaptive volume/pressure support with backup rate)
    Typical indicationsDesigned for complex/central sleep apnea, Cheyne‑Stokes respiration, obesity hypoventilation syndrome, and irregular ventilation patterns
    Relation to codesAdvanced BPAP features referenced in policy when considering E0471 vs E0466 escalation
    Non‑invasive Dual / Multifunction Ventilators — Definition
    Life‑support definitionNon‑invasive dual or multifunction home mechanical ventilators are life‑support devices combining mechanical ventilation with at least two additional respiratory functions
    Examples of functionsSupplemental oxygen delivery, cough assistance, suction, nebulizer delivery, oximetry
    Coverage noteMedical necessity requires documentation of need for additional functions not previously supplied separately
    Mixed Apneas
    Mixed apneas definitionCombination of obstructive and central sleep apnea where both airway obstruction and neurologic or cardiopulmonary dysfunction contribute
    Clinical implicationMay influence device selection and therapy approach per policy
    Diagnostic approachPolysomnography is used to characterize apnea types when indicated
    Obstructive Sleep Apnea (OSA)
    OSA definitionSleep‑related breathing disorder caused by upper‑airway obstruction with recurrent episodes >10 seconds; diagnosed by PSG or home sleep testing with clinical impairment
    SymptomsLoud snoring, witnessed apneas, gasping, excessive daytime sleepiness
    First‑line therapyCPAP supported as first‑line for OSA per policy guidance; BPAP used when CPAP not tolerated or insufficient
    E0470 / E0471 — Code Descriptions
    E0470 / E0471 descriptionsE0470: Respiratory assist device, bi‑level pressure capability, without backup rate; E0471: with backup rate feature
    Use caseReported for BPAP devices used with noninvasive interfaces (nasal or facial mask)
    Coding noteE0472 also listed for invasive interface in code list
    E0466 / E0467 / E0468 — Code Descriptions
    E0466 / E0467 / E0468 descriptionsE0466: Home ventilator any type used with noninvasive interface; E0467: multi‑function home ventilator; E0468: dual‑function home ventilator
    Function examplesE0467/E0468 may perform oxygen concentration, nebulization, aspiration, and cough stimulation in addition to ventilation
    Policy requirementDocumentation must support need for additional functions for E0467/E0468 coverage

    Policy Revision History

    2026-06-18policy_approvalLatest

    Committee approved new policy (1.01.57) establishing coverage for home non-invasive positive pressure ventilation; criteria for BPAP were moved from policy 1.01.06.

    2026-10-15effective_date

    Policy 1.01.57 effective date set for implementation of coverage criteria for home ventilation devices.